ASX - By Stock
|
C79 |
Re:
Hopefully an earnings miss tomorrow
|
|
brnfnktmn
|
13 |
7.6K |
1 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
13
|
7.6K
|
1
|
|
ASX - By Stock
|
C79 |
Re:
Hopefully an earnings miss tomorrow
|
|
brnfnktmn
|
13 |
7.6K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
13
|
7.6K
|
0
|
|
ASX - By Stock
|
C79 |
Re:
Hopefully an earnings miss tomorrow
|
|
brnfnktmn
|
13 |
7.6K |
0 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
13
|
7.6K
|
0
|
|
ASX - By Stock
|
C79 |
Re:
Ann: Full Year Results FY23
|
|
brnfnktmn
|
1 |
815 |
3 |
29/08/23 |
29/08/23 |
ASX - By Stock
|
1
|
815
|
3
|
|
ASX - By Stock
|
TLX |
Re:
Ann: 1H 2023 Results Release
|
|
brnfnktmn
|
4 |
1.8K |
11 |
23/08/23 |
23/08/23 |
ASX - By Stock
|
4
|
1.8K
|
11
|
|
ASX - By Stock
|
C79 |
Re:
News: C79 Chrysos Corporation Posts Qtrly Unaudited Total Revenue Of A$8.6 Mln
|
|
brnfnktmn
|
2 |
1.1K |
1 |
27/07/23 |
27/07/23 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
TLX |
Re:
Ann: Telix-Grand Pharma Investor Webcast Notification
|
|
brnfnktmn
|
38 |
14K |
2 |
17/04/23 |
17/04/23 |
ASX - By Stock
|
38
|
14K
|
2
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Vitura Health joining S&P/ASX All Ordinaries Index
|
|
brnfnktmn
|
92 |
35K |
0 |
15/03/23 |
15/03/23 |
ASX - By Stock
|
92
|
35K
|
0
|
|
ASX - By Stock
|
VIT |
Re:
Ann: Vitura Health joining S&P/ASX All Ordinaries Index
|
|
brnfnktmn
|
92 |
35K |
3 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
92
|
35K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Suspension from Official Quotation
|
|
brnfnktmn
|
69 |
24K |
8 |
04/03/23 |
04/03/23 |
ASX - By Stock
|
69
|
24K
|
8
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Suspension from Official Quotation
|
|
brnfnktmn
|
69 |
24K |
2 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
69
|
24K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Pause in Trading
|
|
brnfnktmn
|
11 |
4.1K |
3 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
11
|
4.1K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Potential Australian market size for Colostat
|
|
brnfnktmn
|
11 |
3.1K |
2 |
01/03/23 |
01/03/23 |
ASX - By Stock
|
11
|
3.1K
|
2
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
brnfnktmn
|
1.5K |
612K |
0 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
1.5K
|
612K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
brnfnktmn
|
1.5K |
612K |
0 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
1.5K
|
612K
|
0
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Quarterly Activities Report
|
|
brnfnktmn
|
30 |
6.0K |
1 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
30
|
6.0K
|
1
|
|
ASX - By Stock
|
TI1 |
Re:
Ann: Quarterly Cashflow Report
|
|
brnfnktmn
|
4 |
1.3K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
4
|
1.3K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
|
|
brnfnktmn
|
12 |
2.9K |
8 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
12
|
2.9K
|
8
|
|
ASX - By Stock
|
TLX |
Re:
TLX Chart
|
|
brnfnktmn
|
1.5K |
612K |
2 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
1.5K
|
612K
|
2
|
|
ASX - By Stock
|
C79 |
Re:
Ann: Chrysos Quarterly Presentation Q2 FY23
|
|
brnfnktmn
|
4 |
5.1K |
4 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
4
|
5.1K
|
4
|
|
ASX - By Stock
|
Iron Ore |
Re:
China to centrally control its mineral imports
|
|
brnfnktmn
|
3 |
1.7K |
0 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
3
|
1.7K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
brnfnktmn
|
17 |
4.5K |
0 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
17
|
4.5K
|
0
|
|
ASX - By Stock
|
NEU |
Re:
Ann: Prader-Willi syndrome IND for NNZ-2591 approved by FDA
|
|
brnfnktmn
|
16 |
10K |
12 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
16
|
10K
|
12
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
brnfnktmn
|
17 |
4.5K |
0 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
17
|
4.5K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: JP Morgan Healthcare Conference and Trading Update
|
|
brnfnktmn
|
135 |
50K |
0 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
135
|
50K
|
0
|
|
ASX - By Stock
|
TLX |
Re:
Ann: JP Morgan Healthcare Conference and Trading Update
|
|
brnfnktmn
|
135 |
50K |
0 |
22/01/23 |
22/01/23 |
ASX - By Stock
|
135
|
50K
|
0
|
|